Celik Alper, Ugale Surendra, Ofluoglu Hasan, Asci Muharrem, Celik Bahri Onur, Vural Erol, Aydin Mustafa
Metabolic Surgery Clinic, Taksim German Hospital, Istanbul, Turkey,
Obes Surg. 2015 Jul;25(7):1184-90. doi: 10.1007/s11695-014-1518-1.
In this study, we specifically aimed to analyze the technical and safety aspects of laparoscopic diverted sleeve gastrectomy with ileal transposition (DSIT) in patients with type 2 diabetes (T2DM).
A total of 360 patients with type 2 diabetes who underwent a DSIT procedure within the past 2-year period (2011-2013) were analyzed. Operation time, length of hospital stay, perioperative and postoperative complications, and mortality were recorded and analyzed.
The participants consisted of 229 males (63.6 %) and 131 females (36.4 %). Mean duration of follow-up was 12.4 months (range, 6-31). One early and two late mortalities occurred. Early mortality was due to an anastomotic leak, and late mortalities were related to myocardial infarction and a traffic accident. Leakage and bleeding were the most common surgical complications. The total number of surgical complications was 22 (6.1 %). Of those, 19 occurred within the first month (early) and 3 occurred after the first month (late). Among early complications, seven (1.94 %) required re-operation, two patients (0.55 %) required endoscopic treatment, and the remaining ten were managed conservatively. Late surgical complications (sleeve angulation) were noted in three patients (0.83) and were treated by endoscopic stents. Surgery-related non-surgical complications occurred in 19 cases (5.2 %), and neurological complications were noted in 11 patients (3.05 %). Additional surgical intervention was required in 26 patients (7.22 %). Of those, 15 (4.16 %) required cholecystectomy.
Our data demonstrate that DSIT is a technically feasible operation and can be safely performed in type 2 diabetic patients with acceptable complication and mortality rates.
在本研究中,我们专门旨在分析腹腔镜转流袖状胃切除术联合回肠转位术(DSIT)在2型糖尿病(T2DM)患者中的技术和安全性方面。
分析了在过去2年期间(2011 - 2013年)接受DSIT手术的360例2型糖尿病患者。记录并分析手术时间、住院时间、围手术期和术后并发症以及死亡率。
参与者包括229名男性(63.6%)和131名女性(36.4%)。平均随访时间为12.4个月(范围6 - 31个月)。发生了1例早期死亡和2例晚期死亡。早期死亡是由于吻合口漏,晚期死亡与心肌梗死和交通事故有关。渗漏和出血是最常见的手术并发症。手术并发症总数为22例(6.1%)。其中,19例发生在第一个月内(早期),3例发生在第一个月后(晚期)。在早期并发症中,7例(1.94%)需要再次手术,2例患者(0.55%)需要内镜治疗,其余10例保守治疗。3例患者(0.83%)出现晚期手术并发症(袖状胃成角),并通过内镜支架治疗。19例(5.2%)发生了与手术相关的非手术并发症,11例患者(3.05%)出现神经并发症。26例患者(7.22%)需要额外的手术干预。其中,15例(4.16%)需要胆囊切除术。
我们的数据表明,DSIT是一种技术上可行的手术,并且可以在2型糖尿病患者中安全地进行,并发症和死亡率可接受。